Thrombin interaction with platelet Gplb Structural mapping and effects on platelet activation (Review)

International Journal of Molecular Medicine

Volumn 3, Issue 4, 1999, Pages 363-371

  De Cristofaro, Raimondo ^a,b   De Candia, Erica ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Heparin; Platelet glycoprotein Ib; Protein protein interaction; Thrombin

Indexed keywords

THROMBIN; THROMBIN RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW; THROMBOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN CONFORMATION; THROMBIN;

EID: 0033111659     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Lopez JA and Dong JF: Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hernatol 4: 323-329, 1997.
2. Nurden AT, Didry D and Rosa J-P: Molecular defects of platelets in Bernard-Soulier syndrome. Blood Cells 9: 333-358, 1983.
3. Buchanan S-ST-C and Gay NJ: Structural and functional diversity in the leucine-rich repeat family of proteins. Prog Biophys Mol Biol 65: 1-44, 1996.
4. Ware J: Molecular analysis of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 79: 466-478, 1998.
5. Wenger RH, Wicki AN, Kieffer N, Adolph S, Hamcister H and Clemetson KJ: The 5′ flanking region and chromosomal localization of the gene encoding human platelet membrane glycoprotein Ibct. Gene 85: 517-524, 1989.
6. Yagi M, Edheloff S, Disteche CM and Roth GJ: Structural characterization and chromosomal localization of the gene encoding human platelet glycoprotein Ibß. J Biol Chem 269: 17424-17427, 1994.
7. Kelly MD, Essex DW, Shapiro SS, Meloni FJ, Druck T, Huebner K and Konkle B A: Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ibß (Gplbß) and localization of the Gplbb gene to chromosome 22. J Clin Invest 93: 2417-2424, 1994.
8. Yagi M, Edheloff S, Disteche CM and Roth GJ: Human platelet glycoproteins V and IX: mapping of two leucine-rich glycoprotein genes to chromosome 3 and analysis of structures. Biochemistry 34: 16132-16137, 1995.
9. Wu G, Essex DW, Meloni FJ, Takafuta T, ujimura K, Konkle BA and Shapiro SS: Human endothelial cells in colture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 90: 2660-2669, 1997.
10. Konkle BA, Shapiro SS, Ash AS and Nachman RL: Cytokineenhanced expression of glycoprotein Iba in human endothelium. J Biol Chem 265: 19833-19838, 1990.
11. Perrault C, Lankhof H, Pidard D, Kerbiriou-Nabias D, Sixma JJ, Mayer D and Baruch D: Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor for its interaction with endothelial cells. Blood 90: 2335-2344, 1997.
12. Wright SD, Michaelides K, Johnson DJD, et al: Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 81: 2339-2347, 1993.
13. Dong J-F, Sae-Tung G and Lopez JA: Role of Glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 89: 4355-4363, 1997.
14. Clemetson KJ: Glycoproteins of the platelet plasma membrane. In: Platelet Membrane Glycoproteins. George JN, Nurden T and Phillips DR (eds). Plenum Press, New York, pp51-85, 1985.
15. Andrews RK and Fox JEB: Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin binding protein. J Biol Chem 267: 18605-18611, 1992.
16. Coller BS: Effects of tertiary amine local anesthetics on alteration of membrane reactivity and degradation of Gplb by a calciumdependent protease(s). Blood 60: 731-743, 1992.
17. Korrel SAM, Clemetson KJ, van Halbeck H, Kamerling Jp, Sixma JJ and Vliegenthart JFG: Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. Eur J Biochem 140: 571-576, 1984.
18. Fox JEB, Aggerbeck LP and Berndt MC: Structure of the glycoprotein Ib-IX complex from platelet membranes. J Biol Chem 263-4882-4890, 1988.
19. Peterson DM, Stathopoulos NA, Giorgio TD, Heliums JD and Moake JL: Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane Glycoprotein Ib and Ilb-IIIa. Blood 69: 625-628, 1987.
20. Lopez JA, Ludwig EH and McCarthy BJ: Polymorphism of human glycoprotein Iba results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem 267: 10055-10061, 1992.
21. Moroi M, Jung SM and Yoshida N: Genetic polymorphism of platelet glycoprotein Ib. Blood 64: 622-629, 1984.
22. Hess D, Schaller J, Rickli EE and Clemetson KJ: Identification of the disulfide bonds in human platelet glycocalicin. Eur J Biochem 199: 389-393, 1991.
23. Titani K, Takio K, Handa M and Rugged ZM: Amino acid sequence of the von Willebrand factorrbinding domain of platelet membrane glycoprotein Ib. Proc NatI Acad Sci USA 84: 5610-5614, 1987.
24. Dong J, Li CQ and Lopez JA: Tyrosine sulfation in the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 33: 13946-13953, 1994.
25. Marchese P, Murata M, Mazzucato M, Pradella P, De Marco L, Ware J and Ruggcri ZM: Identification of three tyrosine residues of glycoprotein Iba with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem 270: 9571-9578, 1995.
26. Okumura T and Jamieson GA: Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem 251: 5944-5949, 1975.
27. Okumura T, Lombart C and Jamieson GA: Platelet glycocalicin. II. Purification and characterization. J Biol Chem 251: 5950-5955, 1976.
28. Bode W, Turk D and Karshikov A: The refined 1.9 A crystal structure of D-PheProArg chloromethylketone inhibited human α-thrombin. Structure analysis, overall structure, electrostatic properties, detailed active site geometry, structure-function relationships. Protein Sci l: 426-471, 1992.
29. Ami RK, Padmanabhan K, Padmanabhan KP, Wu TP and Tulinsky A: Structures of the noncovalent complexes of human and bovine prothrombin factor 2 with human PPACK-thrombin. Biochemistry 32: 4727-4737, 1993.
30. Gralnick JR, Williams LP, McKeown K, Hansmann JW, Fenton JW II and Krutzsch H: High-affinity α-thrombin binding to platelet glycoprotein Iba: identification of two binding domains. Proc Natl Acad Sci USA 91: 6334-6338, 1994.
31. De Marco L, Mazzucato M, Masotti A and Ruggeri ZM: Localization and characterization of an u-thrombin-binding site on platelet glycoprotein Iba. J Biol Chem 269: 6478-6484, 1994.
32. De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M and Landolfi R: Thrombin interaction with platelet Gplb: role of the heparin binding domain. Thromb Haemost 77: 735-740, 1997.
33. De Cristofaro R, De Candia E, Croce G, Morosetti R and Landolfi R: Binding of human α-thrombin to platelet Gplb: energetics and functional effects. Biochem J 332: 643-650, 1998.
34. Olson ST, Halvorson HR and Björk I: Quantitative characterization of the thrombin-heparin interaction. J Biol Chem 266: 6342-6352, 1991.
35. Can ZR, Li Y, Chen Z, Lewis SD and Shafer JA: Identification of basic amino acid residues in thrombin essential for heparincatalyzed inactivation by antithrombin III. J Biol Chem 269: 1301-1305, 1994.
36. Fujimura Y, Kawasaki T and Titani K: Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 76: 633-639, 1997.
37. Ward CM, Andrews RK, Smith AI and Berndt MC: Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Iba. Identification of the sulfated tyrosine/anionic sequence Tyr276-Glu282 of glycoprotein Iba as a binding site for von Willebrand and α-thrombin. Biochemistry 35: 4929-4938, 1995.
38. Jenkins PV, Pasi KJ and Perkins SJ: Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to the von Willebrand's disease. Blood 91: 2032-2044, 1998.
39. Sobel M, McNeill PM, Carlson PL, Kermode JC, Adelman B, Conroy R and Marques D: Heparin inhibition of von Willebrand factor dependent platelet function in vitro and in vivo. J Clin Invests 87: 1787-1792, 1991.
40. Rost B and Sander C: Prediction of protein structure at better than 70% accuracy. J Mol Biol 232: 584-599, 1993.
41. Sturtevant JM: Heat capacity and entropy changes in processes ' involving proteins. Proc Natl Acad Sci USA 74: 2236-2240, 1997.
42. Spolar RS, Ha J-H and Record MT: Hydrophobic effect in protein folding and other noncovalent processes involving proteins. Proc Natl Acad Sci USA 86: 8382-8385, 1989.
43. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C and Fenton J\V II: The structure of a complex of recombinant hirudin and human α-thrombin. Science 249: 277-280, 1990.
44. Fredenburgh JC, Stafford AR and Weitz JI: Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem 272: 25493-25499, 1997.
45. Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, Turck CW, Coughlin SR and Fenton JW II: Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 33: 3266-3279, 1994.
46. Brass LF and Molino M: Protease-activated G protein-coupled receptors on human platelets and endothelial cells. Thromb Haemost 78: 234-241, 1997.
47. 2+] induced by α-thrombin. Biochemistry 35: 906-914, 1996.
48. Greco NJ, Jones GD, Narendra NT, Kornhauser R, Jackson B and Jamieson GA: Differentiation of two forms of Gplb functioning as receptors for α-thrombin and von Willebrand factor: Ca responses of protease-treated human platelets activated with αthrombin and the tethered ligand peptide. Biochemistry 35: 915-921, 1996.
49. De Marco L, Mazzucato M, Masotti A, Fenton II JW and -., Ruggeri ZM: Function of glycoprotein Iba in platelet activation induced by α-thrombin. J Biol Chem 266: 23776-23783, 1991.
50. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ and Berndt MC: Characterization of an anti-glycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res 62: 673-684, 1991.
51. Peng M, Emig FA, Mao A, Lu W, Kirby EP, Niewiarowski S and Kovvalska MA: Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein Ib. Thromb Haemost 74: 954-957, 1 995.
52. Vu T-K, Hung D, Wheaton V and Coughlin S: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
53. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr and Coughlin SR: Role of the thrombin receptor in development and evidence for a second receptor. Nature 381: 516-519, 1996.
54. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T and Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502-506, 1997.
55. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tarn C and Coughlin SR: A dual thrombin receptor system for platelet activation. Nature 394: 690-694, 1998.
56. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW and Foster DC: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95: 6642-6646, 1998.
57. Henriksen RA; Samokhin GP and Tracy PB: Thrombin-induced thromboxane synthesis by human platelets. Properties of anion binding exosite I-independent receptor. Arterioscler Thromb Vase Biol 17: 3519-3516, 1997.
58. Lasne D, Donato J, Falet H and Rendu F: Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction. Thromb Haemost 74: 1323-1328, 1995.
59. 2 independent of the mitogen-activated protein kinases ERK1/2. J Biol Chem 270: 14816-14823, 1995.
60. Lau LF, Pumiglia K, Côté YP and Feinstein MB: Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem J 303: 391-400, 1994.
61. Kroll MH, Harris TS, Moake JL, Handin RI and Schafer AI: von Willebrand factor binding to platelet Gplb initiates signals for platelet activation. J Clin Invest 88: 1568-1573, 1991.
62. Chow TW, Heliums JD, Moake JL and Kroll MH: Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aegregation. Blood 80: 113-120, 1992.
63. Razdan K, Heliums JD and Kroll MH: Shear stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302: 661-666, 1993.
64. Andrews RK, Kroll MH, Ward CM, Rose JVV, Scarborough RM, Smith AI, Lopez JA and Berndt MC: Binding of a novel 50-kDa alboaggregin from Trimcresiirus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex: effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 35: 12629-12639, 1996.
65. Greco NJ and Jamieson GA: High and moderate affinity pathways for α-thrombin-induced platelet activation. Proc Soc Exp Biol Med 198: 792-799, 1991.
66. Jamieson GA: Pathophysiology of platelet thrombin receptors. Thromb Haemost 78: 242-246, 1997.
67. Huang R-S, Sorissky A, Church WR, Simons ER and Rittenhouse SE: Thrombin receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J Biol Chem 266: 18435-18438, 1991.
68. 2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 269: 18287-18290, 1994.
69. Jones DH, Leys S and Aitken A: Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett 368: 55-58, 1995.
70. Burbelo PD and Hall A: 14-3-3 proteins. Hot numbers in signal transduction. Curr Biol 5: 95-103, 1995.
71. Morrison D: 14-3-3: modulators of signaling proteins? Science 266: 56-59, 1994.
72. Calverley DC, Kavanagh TJ and Roth GJ: Human signaling protein 14-3-3ζ interacts with platelet glycoprotein Ib subunits Iba and Ibβ. Blood 91: 1295-1303, 1998.
73. Kovacsovics TJ and Hartwig JH: Thrombin-induced GpIb-IX centralization on the platelet surface requires assembly and myosin II activation. Blood 87: 618-629, 1996.
74. Wang D, Gou SY and Axelrod D: Reaction rate enhancement by surface diffusion of adsorbates. Biophys Chem 43: 117-137, 1992.
75. Axelrod D and Wang D: Reduction of dimensionality kinetics at reaction-limited cell surface receptors. Biophys J 66: 588-600, 1994.
76. McGowan EB, Ding A-H and Detwiler TC: Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J Biol Chem 258: 11243-11248, 1983.
77. White GC II and Knupp CL: Glycoprotein V hydrolysis by thrombin. Lack of correlation with secretion. Thromb Res 38: 641-648, 1985.
78. Gonzalez-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM and Vicente V: Polymorphisms of platelet membrane glycoprotein Iba associated with arterial thrombotic disease. Blood 92: 2771-2776, 1998.